For News, please consult our Twitter channel: https://twitter.com/bme_mcgill
2016 Jun 8 - Particles that point to cancer - Dr. David Juncker's reasearch featured in McGill Mdicine Focus magazine
The first steps to better cancer treatment start with identifying the disease.
Over at the McGill University and Génome Québec Innovation Centre, Dr. David Juncker and his team are investigating cancer diagnostics and screening technologies in the Micro & Nano Bioengineering Lab.
One tool is a filtration technique to isolate cells that could be linked to cancer, based on size, but also based on molecular features. The initial work was done at the McGill Nanotools Microfab, a facility dedicated to developing micro- and nanotechnologies, says Juncker, a Canada Research Chair in Micro- and Nanobioengineering and Professor in Biomedical Engineering at McGill.
The microfabricated filters are engineered to catch circulating tumour cells, which could signal whether cancer has spread.
“The next step is to go to the clinic and try this setup with patient samples,” Juncker says.
Juncker’s lab is also developing microfluidics and microarrays, both of which are techniques using “lab-on-a chip” technologies that function like mini-laboratories, testing samples for particles that could point to cancer.
“What you need is to have technologies that are user-friendly and economically viable and also provide actionable information in the end,” Juncker says. “There’s still a big gap there.”
The goal is to use biomarker signatures with the new technologies in diagnostics for cancer patients. Using blood samples and microarrays—chips with dots that measure proteins—Juncker and his team are looking to identify breast cancer biomarkers, which are molecules released by tumours. These molecules are signs that cancer is present in the body.
For the full story see the Medicine Focus magazine.
2016 May 31 - Congratulations to BME graduates - Spring 2016 Convocation
2016 Apr 14 - BME welcomes Professor Ahmad Haidar
2016 Feb 18 - Professor David Juncker promotion to Full Professor
Congratulations to Prof. David Juncker upon his promotion to Full Professor. It is a well-deserved recognition!
Professor Juncker earned his PhD from the University of Neuchâtel in Switzerland. He joined McGill in 2005. His research focus is on the miniaturization and integration in biology and medicine, which includes using micro- and nano-technology in the study of proteins, cells and tissues. He has developed a multipurpose fluidic probe, which can be used for making micro-arrays, manipulating single cells, and for the study of cell migration and diagnostics. He is an associate member of the Departments of Surgery, Medicine, Neurology and Neurosurgery, Bioengineering and Electrical and Computer Engineering.
Details in McGill Reporter
2015 Oct 31 - Professor Thomas M.S. Chang receives Chinese-Canadian Legend award
Known as the “father of artificial cells”, Prof. Chang created the first artificial cell in the world in 1956, which brought forth many ground-breaking approaches in human health and other applications. Professor Emeritus in the departments of Physiology, Medicine and Biomedical Engineering and Director of the Artificial Cells and Organs Research Centre at McGill, to this day Prof. Chang continues his research and innovative work to better the future of humankind. He was awarded Officer of the Order of Canada and was twice nominated for the Nobel Prize. In 2011, Dr. Chang was voted the winner of the Greatest McGillian contest organized by the McGill Alumni Association for McGill’s 190th anniversary.
For the full story see the the Live 2015 of the Med-eNews.
2015 Aug 28 - BME at the 37th Annual International Conference of the IEEE Engineering in Medicine and Biology Society in Milano, Italy
The new program Biological and Biomedical Engineering was being promoted at the IEEE EMBC conference.
2014 Dec 18 - Chair re-appointed. Professor Robert Kearney has been reappointed as Interim Chair for an additional two years, effective Jan. 1, 2015.
Dr. Kearney has accepted this reappointment to provide some stability and continuity in this leadership role within the Department. The longer term also allows Dr. Kearney to continue his efforts in strengthening the relationship with Bioengineering with the ultimate goal of establishing a structure beneficial to both faculties and departments.
2014 Oct 29 - Pina Sorrini wins Principal's Award in the Managerial category
“I wouldn’t trade my job for anything. I love it! I love helping students in any way I can. Even if sometimes it’s just as someone to listen to them when they need to talk.” - Pina Sorrini, Student Affairs Officer in the Department of Biomedical Engineering.
For the full story see the the November 18, 2014 issue of the McGill Reporter
2013 Feb 1 – NEW Graduate Program Director. Professor Louis Collins has been appointed Graduate Program Director.